MTHFD2通过IFRD1RNA m6A甲基化介导的HDAC3/p53/mTOR通路促进乳腺癌细胞的增殖
Qingqing Zhang1, Jun Mao2, Luhan Xie1
1Department of Pathology and Forensic Medicine, College of Basic Medical Sciences, Dalian Medical University, Dalian, China.
Neoplasma
|January 20, 2025
概括
通过调节IFRD1RNA甲基化和HDAC3/p53/mTOR通路,MTHFD2过度表达驱动乳腺癌细胞的增殖. 向MTHFD2可能会提高化疗的疗效.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 在乳腺癌中,MTHFD2 (甲基基酸脱酶2) 过度表达.
- 它在乳腺癌进展中的作用和潜在的分子机制需要阐明.
研究的目的:
- 研究MTHFD2在乳腺癌细胞增殖中的功能.
- 为了确定由MTHFD2调节的分子通路,包括m6A甲基化.
- 探索MTHFD2作为乳腺癌的潜在治疗点.
主要方法:
- 对MTHFD2和下游目标的生物信息分析.
- 工程乳腺癌细胞系与改变的MTHFD2表达 (过度表达和淘汰).
- 评估细胞循环,增殖 (EdU测试),IFRD1的m6A甲基化,用于途径蛋白的西部涂抹 (HDAC3,mTOR,p70 S6K,4EBP1,p53) 和化学敏感性测试.
主要成果:
- MTHFD2过度表达增强了增殖,S+G2/M阶段进展,以及IFRD1表达和m6A甲基化.
- 但是,MTHFD2的抗击方法却产生了相反的效果.
- MTHFD2调节了HDAC3/p53/mTOR通路,影响了p70 S6K和4EBP1的激活和p53的乙化.
- 抑制IFRD1可逆转MTHFD2诱导的增殖,而抑制MTHFD2可增加对化疗的敏感性.
结论:
- MTHFD2通过IFRD1 m6ARNA甲基化促进乳腺癌细胞的增殖,影响HDAC3/p53/mTOR信号轴.
- MTHFD2是一种潜在的治疗标,MTHFD2抑制剂可以提高化疗的有效性.
更多相关视频
10:39Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
13.1K
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
23.3K
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
